Authors: AVENT KM RIKER RR FRASER GL VANDERSCHYF CJ USUKI E POND SM

Citation: Km. Avent et al., METABOLISM OF HALOPERIDOL TO PYRIDINIUM SPECIES IN PATIENTS RECEIVINGHIGH-DOSES INTRAVENOUSLY - IS HPTP AN INTERMEDIATE, Life sciences, 61(24), 1997, pp. 2383-2390

Authors: AVENT KM USUKI E EYLES DW KEEVE R VANDERSCHYF CJ CASTAGNOLI N POND SM

Citation: Km. Avent et al., HALOPERIDOL AND ITS TETRAHYDROPYRIDINE DERIVATIVE (HPTP) ARE METABOLIZED TO POTENTIALLY NEUROTOXIC PYRIDINIUM SPECIES IN THE BABOON, Life sciences, 59(17), 1996, pp. 1473-1482

Authors: IGARASHI K KASUYA F FUKUI M USUKI E CASTAGNOLI N

Citation: K. Igarashi et al., STUDIES ON THE METABOLISM OF HALOPERIDOL (HP) - THE ROLE OF CYP3A IN THE PRODUCTION OF THE NEUROTOXIC PYRIDINIUM METABOLITE HPP-BRAIN FOLLOWING IP ADMINISTRATION OF HP( FOUND IN RAT), Life sciences, 57(26), 1995, pp. 2439-2446

Authors: VANDERSCHYF CJ CASTAGNOLI K USUKI E FOUDA HG RIMOLDI JM CASTAGNOLI N

Citation: Cj. Vanderschyf et al., METABOLIC STUDIES ON HALOPERIDOL AND ITS TETRAHYDROPYRIDINE ANALOG INC57BL 6 MICE/, Chemical research in toxicology, 7(3), 1994, pp. 281-285

Authors: ROLLEMA H SKOLNIK M DENGELBRONNER J IGARASHI K USUKI E CASTAGNOLI N

Citation: H. Rollema et al., MPP(-LIKE NEUROTOXICITY OF A PYRIDINIUM METABOLITE DERIVED FROM HALOPERIDOL - IN-VIVO MICRODIALYSIS AND IN-VITRO MITOCHONDRIAL STUDIES()), The Journal of pharmacology and experimental therapeutics, 268(1), 1994, pp. 380-387